Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institute for Behavior and Health (IBH) is a non-profit research and policy organization focused on reducing drug use and addiction. Established in 1978 by Dr. Robert L. DuPont, the first Director of the National Institute on Drug Abuse (NIDA), IBH develops and promotes innovative strategies for drug prevention, treatment, and recovery. The organization is well-known for its 'One Choice' initiative, which encourages youth to avoid all alcohol, nicotine, and other drugs for health. IBH also conducts significant work in the areas of drugged driving policy and the 'New Paradigm' for long-term recovery management. It serves as a resource for policymakers and healthcare leaders seeking evidence-based solutions to the drug epidemic.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute for Behavior and Health.